Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries Ltd: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Tissue Science 2018

About Conference


The 9th International conference  on Tissue Engineering and Regenerative Medicine which is going to be held during November 9-10 2018 at Atlanta, Georgia, USA  will  bring together world-class personalities working on stem cells, tissue engineering and  regenerative medicine to discuss materials-related strategies for disease remediation and tissue repair. Bone tissue engineeringsoft tissuestissue imagingtissue implant, cartilage and skin defects are a special focus along with applying basic science and engineering principles from diverse areas towards solving clinically relevant biomedical problems.

We welcome you to Tissue Science Conference, to be held on November 9-10 2018 at Atlanta, Georgia, USA. This conference presents information regarding cutting-edge developments in all areas of tissue engineering, stem cell research, regenerative medicine research including the biology, medicine, applications and regulations of stem cells. Topics of discussion include recent developments in pre-clinical and clinical trials of stem cell therapy, regenerative medicine and tissue engineering, cancer stem cells, immunotherapy, stem cell reprogramming, and regulatory policies regarding stem cell research.

After the success of the 6th international Conference  on Tissue Engineering and Regenerative Medicine  in 2017, it’s time for the tissue engineering and regenerative medicine industries to come together and looking forward for  the  next 10 years of commercial successes within these two sectors.

The World Conference on Regenerative Medicine  has traditionally focused on developing the commercial aspects of  tissue science research  with the addition of innovation within stem cellsregenerative medicine, notably tissue engineering.

Now the first regenerative medicine therapies have made it to market, it is important, for the success of the sector, to move forward and include new projects and innovations that are coming out of academia and university spin-outs. These will be both new developments in regenerative medicine research but also within the use of tissue engineering and stem cells for drug discovery.

Alongside the stem cells content, there is an increasing amount of demand for other forms of regenerative medicine and so the Tissue Science conference will move to include more commercial opportunities within the field of tissue engineering: markedly biological scaffolds, 3D bio printing and organ regeneration.

Through the last 5 years the Tissue Science Conference has built up a reputation for delivering high-level commercial content and bringing together the senior executives and thought-leaders within the space.

Sessions And Tracks

Tissue engineering is an interdisciplinary field that applies the principles of engineering and life sciences toward the development of biological substitutes that restore, maintain, or improve tissue function or a whole organ. Currently it has emerged as a rapidly diversifying field with the potential to address the worldwide organ shortage issue and comprises of tissue regeneration and organ replacement. The global tissue engineering and regeneration market reached $17 billion in 2017. This market is expected to grow to nearly $20.8 billion in 2014 and $56.9 billion in 2019, a compound annual growth rate (CAGR) of 22.3%. On the basis of geography, Europe holds the second place in the global market in the field of regenerative medicine & tissue engineering. In Europe countries like UK, France and Germany are possessing good market shares in the field of regenerative medicine and tissue engineering. Spain and Italy are the emerging market trends for tissue engineering in Europe.

The 9th International Conference on Tissue Engineering and Regenerative Medicine which is going to be held during November 9-10, 2018 at Atlanta, USA will bring together world-class personalities working on stem cells, tissue engineering and regenerative medicine to discuss materials-related strategies for disease remediation and tissue repair. 

Tissue Regeneration

In the field of biology, regeneration is the progression of renewal, regeneration and growth that makes it possible for genomes, cells, organ regeneration to natural changes or events that cause damage or disturbance. This study is carried out as craniofacial tissue engineering, in-situ tissue regeneration, adipose-derived stem cells for tissue science which is also a breakthrough in cell culture technology. The study is not stopped with the regeneration of tissue where it is further carried out in relation with cell signaling, morphogenetic proteins. Most of the neurological disorders occurred accidental having a scope of recovery by replacement or repair of intervertebral discs repair, spinal fusion and many more advancements. The global market for tissue engineering and regeneration products such as scaffolds, tissue implants, biomimetic materials reached $55.9 billion in 2010 and it is expected to reach $89.7 billion by 2018 at a compounded annual growth rate (CAGR) of 8.4%.  It grows to $135 billion by 2024.

Related Conferences

Drug delivery and tissue engineering conference 2018, February 4-8, 2018, Singapore; 20th International conference on Tissue engineering and Biomaterials, Feb 19-20, 2018, Paris; Global Summit on Stem Cell & Tissue Engineering 2018, July 23-24, 2018 Barcelona, Spain.19th International Conference on Tissue Engineering and Regenerative Medicine Applications, September21-22, Paris, France; 9th International conference on Tissue Engineering and Regenerative Medicine, November 9-10 Atlanta;3rd world Congress on Human Genetics & Genetic Disorders, October 20-21,2017,Canada; 9th International conference on Tissue Preservation & Biobanking, November 9-10, Atlanta;7th Annual Congress & Medical Expo on Primary Health Care and Nursing 2018,June 25-26,Canada.

Biological Tissue Substitutes

Bioengineered skin and soft tissue substitutes may be derived from human tissue (autologous or allogeneic), nonhuman tissue (xenographic), synthetic materials, or a composite of these materials. Bioengineered skin and soft tissue substitutes are being evaluated for a variety of conditions, including breast reconstruction and healing lower-extremity ulcers and severe burns. Acellular dermal matrix (ADM) products are also being evaluated for soft tissue repair.

Related Conferences

Drug delivery and tissue engineering conference 2018, February 4-8, 2018, Singapore; 20th International conference on Tissue engineering and Biomaterials, Feb 19-20, 2018, Paris; Global Summit on Stem Cell & Tissue Engineering 2018, July 23-24, 2018 Barcelona, Spain.19th International Conference on Tissue Engineering and Regenerative Medicine Applications, September21-22, Paris, France; 9th International conference on Tissue Engineering and Regenerative Medicine, November 9-10 Atlanta;3rd world Congress on Human Genetics & Genetic Disorders, October 20-21,2017,Canada; 9th International conference on Tissue Preservation & Biobanking, November 9-10, Atlanta;7th Annual Congress & Medical Expo on Primary Health Care and Nursing 2018,June 25-26,Canada.

Bone Tissue Engineering

Tissue engineering of musculoskeletal tissues, particularly bone and cartilage, is a rapidly advancing field. In bone, technology has centered on bone graft substitute materials and the development of biodegradable scaffolds. Recently, tissue engineering strategies have included cell and gene therapy. The availability of growth factors and the expanding knowledge base concerning the bone regeneration with modern techniques like recombinant signaling molecules, solid free form fabrication of scaffolds, synthetic cartilage, Electrochemical deposition, spinal fusion and ossification are new generated techniques for tissue engineering applications. The worldwide market for bone and cartilage repairs strategies is estimated about $300 million. During the last 10/15 years, the scientific community witnessed and reported the appearance of several sources of stem cells with both osteon and chondrogenic potential.

Related Conferences

Drug delivery and tissue engineering conference 2018, February 4-8, 2018, Singapore; 20th International conference on Tissue engineering and Biomaterials, Feb 19-20, 2018, Paris; Global Summit on Stem Cell & Tissue Engineering 2018, July 23-24, 2018 Barcelona, Spain.19th International Conference on Tissue Engineering and Regenerative Medicine Applications, September21-22, Paris, France; 9th International conference on Tissue Engineering and Regenerative Medicine, November 9-10 Atlanta;3rd world Congress on Human Genetics & Genetic Disorders, October 20-21,2017,Canada; 9th International conference on Tissue Preservation & Biobanking, November 9-10, Atlanta;7th Annual Congress & Medical Expo on Primary Health Care and Nursing 2018,June 25-26,Canada.

Cell Culture & Bio Reactors

Bioreactors come in a variety of sizes, shapes, and forms. Single-use bioreactors for cell culture were introduced to the market in the mid-90s and they are now widely used in process development, research, and manufacturing up to 2000 L scale. Disposable technology brings an increased speed and flexibility to bioprocessing and decreases cleaning validation costs.

Related Conferences

Drug delivery and tissue engineering conference 2018, February 4-8, 2018, Singapore; 20th International conference on Tissue engineering and Biomaterials, Feb 19-20, 2018, Paris; Global Summit on Stem Cell & Tissue Engineering 2018, July 23-24, 2018 Barcelona, Spain.19th International Conference on Tissue Engineering and Regenerative Medicine Applications, September21-22, Paris, France; 9th International conference on Tissue Engineering and Regenerative Medicine, November 9-10 Atlanta;3rd world Congress on Human Genetics & Genetic Disorders, October 20-21,2017,Canada; 9th International conference on Tissue Preservation & Biobanking, November 9-10, Atlanta;7th Annual Congress & Medical Expo on Primary Health Care and Nursing 2018,June 25-26,Canada.

Patient Specific Drug Discovery

In vitro cell models are invaluable tools for studying diseases and discovering drugs. Human induced pluripotent stem cells, particularly derived from patients, are an advantageous resource for generating sample supplies of cells to create unique platforms that model disease. This manuscript will review recent developments in modeling a variety of diseases (including their cellular phenotypes) with induced pluripotent stem cells derived from patients. It will also describe how researchers have exploited these models to validate drugs as potential therapeutics for these devastating diseases.

Related Conferences

Drug delivery and tissue engineering conference 2018, February 4-8, 2018, Singapore; 20th International conference on Tissue engineering and Biomaterials, Feb 19-20, 2018, Paris; Global Summit on Stem Cell & Tissue Engineering 2018, July 23-24, 2018 Barcelona, Spain.19th International Conference on Tissue Engineering and Regenerative Medicine Applications, September21-22, Paris, France; 9th International conference on Tissue Engineering and Regenerative Medicine, November 9-10 Atlanta;3rd world Congress on Human Genetics & Genetic Disorders, October 20-21,2017,Canada; 9th International conference on Tissue Preservation & Biobanking, November 9-10, Atlanta;7th Annual Congress & Medical Expo on Primary Health Care and Nursing 2018,June 25-26,Canada..

Tooth Regeneration

Tooth regeneration is a stem cell based regenerative medicine procedure in the field of tissue engineering and stem cell biology to replace damaged or lost teeth by regrowing them from autologous stem cells.

As a source of the new bioengineered teeth somatic stem cells are collected and reprogrammed to induced pluripotent stem cells which can be placed in the dental lamina directly or placed in a reabsorbable biopolymer in the shape of the new tooth .

Related Conferences

Drug delivery and tissue engineering conference 2018, February 4-8, 2018, Singapore; 20th International conference on Tissue engineering and Biomaterials, Feb 19-20, 2018, Paris; Global Summit on Stem Cell & Tissue Engineering 2018, July 23-24, 2018 Barcelona, Spain.19th International Conference on Tissue Engineering and Regenerative Medicine Applications, September21-22, Paris, France; 9th International conference on Tissue Engineering and Regenerative Medicine, November 9-10 Atlanta;3rd world Congress on Human Genetics & Genetic Disorders, October 20-21,2017,Canada; 9th International conference on Tissue Preservation & Biobanking, November 9-10, Atlanta;7th Annual Congress & Medical Expo on Primary Health Care and Nursing 2018,June 25-26,Canada.

Regenerative medicine

Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function. The latest developments involve advances in cell and gene therapy and stem cell research, molecular therapy, dental and craniofacial regeneration. Regenerative medicine have the unique ability to repair, replace and regenerate tissues and organs, affected due to some injury, disease or due to natural aging process. These medicines are capable of restoring the functionality of cells and tissues. The global regenerative medicine market will reach $ 67.6 billion by 2020 from $16.4 billion in 2013, registering a CAGR of 23.2% during forecast period (2014 - 2020). Small molecules and biologics segment holds prominent market share in the overall regenerative medicine technology market and is anticipated to grow at a CAGR of 18.9% during the forecast period.

Related Conferences

Drug delivery and tissue engineering conference 2018, February 4-8, 2018, Singapore; 20th International conference on Tissue engineering and Biomaterials, Feb 19-20, 2018, Paris; Global Summit on Stem Cell & Tissue Engineering 2018, July 23-24, 2018 Barcelona, Spain.19th International Conference on Tissue Engineering and Regenerative Medicine Applications, September21-22, Paris, France; 9th International conference on Tissue Engineering and Regenerative Medicine, November 9-10 Atlanta;3rd world Congress on Human Genetics & Genetic Disorders, October 20-21,2017,Canada; 9th International conference on Tissue Preservation & Biobanking, November 9-10, Atlanta;7th Annual Congress & Medical Expo on Primary Health Care and Nursing 2018,June 25-26,Canada.

Bone Tissue Engineering

Tissue engineering of musculoskeletal tissues, particularly bone and cartilage, is a rapidly advancing field. In bone, technology has centered on bone graft substitute materials and the development of biodegradable scaffolds. Recently, tissue engineering strategies have included cell and gene therapy. The availability of growth factors and the expanding knowledge base concerning the bone regeneration with modern techniques like recombinant signaling molecules, solid free form fabrication of scaffolds, synthetic cartilage, Electrochemical deposition, spinal fusion and ossification are new generated techniques for tissue-engineering applications. The worldwide market for bone and cartilage repairs strategies is estimated about $300 million. During the last 10/15 years, the scientific community witnessed and reported the appearance of several sources of stem cells with both osteon and chondrogenic potential.

Related Conferences

Drug delivery and tissue engineering conference 2018, February 4-8, 2018, Singapore; 20th International conference on Tissue engineering and Biomaterials, Feb 19-20, 2018, Paris; Global Summit on Stem Cell & Tissue Engineering 2018, July 23-24, 2018 Barcelona, Spain.19th International Conference on Tissue Engineering and Regenerative Medicine Applications, September21-22, Paris, France; 9th International conference on Tissue Engineering and Regenerative Medicine, November 9-10 Atlanta;3rd world Congress on Human Genetics & Genetic Disorders, October 20-21,2017,Canada; 9th International conference on Tissue Preservation & Biobanking, November 9-10, Atlanta;7th Annual Congress & Medical Expo on Primary Health Care and Nursing 2018,June 25-26,Canada.

Cell Culture & Bio Reactors

Bioreactors come in a variety of sizes, shapes, and forms. Single-use bioreactors for cell culture were introduced to the market in the mid-90s and they are now widely used in process development, research, and manufacturing up to 2000 L scale. Disposable technology brings an increased speed and flexibility to bioprocessing and decreases cleaning validation costs.

Related Conferences

Drug delivery and tissue engineering conference 2018, February 4-8, 2018, Singapore; 20th International conference on Tissue engineering and Biomaterials, Feb 19-20, 2018, Paris; Global Summit on Stem Cell & Tissue Engineering 2018, July 23-24, 2018 Barcelona, Spain.19th International Conference on Tissue Engineering and Regenerative Medicine Applications, September21-22, Paris, France; 9th International conference on Tissue Engineering and Regenerative Medicine, November 9-10 Atlanta;3rd world Congress on Human Genetics & Genetic Disorders, October 20-21,2017,Canada; 9th International conference on Tissue Preservation & Biobanking, November 9-10, Atlanta;7th Annual Congress & Medical Expo on Primary Health Care and Nursing 2018,June 25-26,Canada.

Patient Specific Drug Discovery

In vitro cell models are invaluable tools for studying diseases and discovering drugs. Human induced pluripotent stem cells, particularly derived from patients, are an advantageous resource for generating sample supplies of cells to create unique platforms that model disease. This manuscript will review recent developments in modeling a variety of diseases (including their cellular phenotypes) with induced pluripotent stem cells derived from patients. It will also describe how researchers have exploited these models to validate drugs as potential therapeutics for these devastating diseases.

Related Conferences

Drug delivery and tissue engineering conference 2018, February 4-8, 2018, Singapore; 20th International conference on Tissue engineering and Biomaterials, Feb 19-20, 2018, Paris; Global Summit on Stem Cell & Tissue Engineering 2018, July 23-24, 2018 Barcelona, Spain.19th International Conference on Tissue Engineering and Regenerative Medicine Applications, September21-22, Paris, France; 9th International conference on Tissue Engineering and Regenerative Medicine, November 9-10 Atlanta;3rd world Congress on Human Genetics & Genetic Disorders, October 20-21,2017,Canada; 9th International conference on Tissue Preservation & Biobanking, November 9-10, Atlanta;7th Annual Congress & Medical Expo on Primary Health Care and Nursing 2018,June 25-26,Canada.

Market Analysis

USA: Regenerative medicines market by therapy (cell therapy, gene therapy, immunotherapy, tissue engineering), region - global forecast to 2021, the global regenerative medicines market size is expected to reach USD 49.41 billion by 2021,. North America contributed the largest share in the global regenerative medicines market, and was dominated largely by the USA

 

Europe: The global tissue engineering and regeneration market reached $17 billion in 2016. This market is expected to grow to nearly $20.8 billion in 2014 and $56.9 billion in 2019, Today, there are 640 privately held and publicly traded companies in Europe, Japan, and the U.S.

 

Middle East: Middle East and Africa regenerative medicines market is expected to reach USD 5.75 billion by 2021 from USD 2.03 billion in 2018, growing at a CAGR of 23.15% during the forecast period 2016-2021. Regenerative medicines repair, replace or regenerate human cells, tissues, or organs affected due to injury, disease, aging processes, congenital defects, and damage due to trauma.

 

Asia Pacific: Asia-Pacific regenerative medicines market is expected to reach USD 10.71 billion by 2021 from USD 3.01 billion in 2017, growing at a CAGR of 28.90% during the forecast period 2017-2021.  Cell-based products segment is estimated to account for larger share of Asia-Pacific regenerative medicines market by product in 2018.

 

 

 

Past Conference Report

Tissue Science 2017

Tissue Science 2017 Report

6th International Conference on Tissue Engineering and Regenerative Medicine was organized during August 23-24, 2017 at San Francisco, USA. The conference was marked with the attendance of Editorial Board Members of supporting journals, Scientists, young and brilliant researchers, business delegates and talented student communities representing more than 25 countries, who made this conference fruitful and productive.

This conference was based on the theme “Importance of Tissue Engineering and Regenerative Medicine to the Future of Health Care” which included the following scientific tracks:

  • Tissue Regeneration using Nanotechnology
  • Tissue Repair and Regeneration
  • Biological Tissue Substitutes
  • Organ Engineering
  • Trends in Tissue Engineering
  • Bone Tissue Engineering
  • Cell Culture & Bio Reactors
  • Patient Specific Drug Discovery
  • Tooth Regeneration
  • Regenerative medicine
  • Applications of Tissue Engineering
  • Regenerative Medicine Market
  • Embryonic Stem Cell
  • Stem Cell Transplant

The Organizing Committee would like to thank the moderator Dr. Joel I Osorio (University of Californian Los Angeles, USA) and Dr. Seungil Ro for their contribution which resulted in smooth functioning of the conference.

The conference proceeded through various scientific sessions and plenary lectures, of which the following topics were highlighted as Keynote presentations:

Panayiotis Zavos -The Evolution and Current Status of Sperm Cryopreservation (The Andrology Institute of America, USA)

Heiko Zimmerman- Improved methods and procedures for pluripotent stem cell preservation, storage stability and validation (Fraunhofer Institute for Biomedical Engineering, Germany)

Aubrey de Grey- Cryopreservation of organs and organisms: Signs of a new era  (SENS Research Foundation, USA)

Igor Katkov- Cryopreservation by Vitrification: Basic Thermodynamic Principals, Methods and Devices (Belgorod National Research University, Russia)

Ken Yaegaki- Transplantation of hepatocyte like cells derived from human tooth into the animals with liver conditions (Nippon Dental University School of Life Dentistry, Japan)

Charles F Mahl- Prolotherapy – The first choice in Regenerative Medicine (GenLife Institute for Regenerative Medicine and Stem Cells, USA)

Luiz C. Samapio - Maximizing Cardiac Repair: Should We Focus on Cells or Matrix?( Texas Heart Institute, USA)

Various sessions were chaired and co-chaired by: Panayiotis Zavos, The Andrology Institute of America, USA; Heiko Zimmerman, Fraunhofer Institute for Biomedical Engineering, Germany and
Debra Aub Webster, Cardinal Health Regulatory Sciences, USA; Ken Yaegaki, Nippon Dental University School of Life Dentistry, Japan

 Conferenceseries LLC has taken the privilege of felicitating Tissue Science 2017 Organizing Committee, Editorial Board Members and Keynote Speakers who supported for the success of this conference.

The esteemed guests, keynote speakers and researchers shared their innovative research and vast experience through their informative presentations at the podium of Tissue Science 2017. We are glad to inform that all accepted abstracts for the conference have been published in Journal of Tissue Science & engineering: Open Access as a special issue.

We are also obliged to various experts, company representatives and other eminent scientists who supported the conference by facilitating the discussion forums. We sincerely thank the Organizing Committee Members for their gracious presence, support, and assistance. With the unique feedback from the conference, Conferenceseries LLC would like to proudly announce the commencement of the “9th International Conference on Tissue Engineering and Regenerative Medicine “to be organized during November 7-8, 2017 at Atlanta, USA.

Mark your calendars for the upcoming Conference; we are hoping to see you soon!

For More details: http://tissuescience.conferenceseries.com/


Past Reports  Proceedings  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date November 9-10 , 2018

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Supported By

Journal of Tissue Science & Engineering Journal of Biomimetics Biomaterials and Tissue Engineering Journal of Cell Science & Therapy

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators & Sponsors

mediapartner

Media Partner

mediapartner

Media Partner